Plain-English translation of NCT06185920 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is an observational study that gathers medical information from patients treated with bacteriophage therapy at Hospices Civils de Lyon in France. Bacteriophages are viruses that can attack and kill harmful bacteria, and this study aims to understand how well this treatment works for people with severe infections and what happens to them over time.
Some severe bacterial infections are becoming resistant to standard antibiotics, making them harder to treat. This medication offers a promising alternative approach, and doctors need to collect real-world experience to better understand how it works, who benefits most, and what outcomes patients can expect.
You likely qualify if…
You likely don't qualify if…
As a participant, you would allow the research team to review and collect your medical records from your treatment at the hospital. The study is non-interventional, meaning you would not receive any new treatment or procedures—the researchers are simply gathering information about your care and recovery. This is a retrospective and prospective study, so it includes both past medical records and may follow patients going forward.
AI-generated summary from trial data · Oct 12, 2026 · Not medical advice
France
Enrollment target
~250 participants
Started
February 2023
Primary completion
February 2033
Last updated on clinicaltrials.gov in December 2023.
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.